Table
1: Clinical
features upon initial presentation.
|
1 |
2 |
3 |
4 |
5 |
Age/Sex |
72F |
81F |
77F |
68F |
72F |
Diagnosis |
SSc (diffuse) |
SSc (diffuse) |
SSc (diffuse) |
SSc (diffuse) |
SSc (diffuse) |
Presenting complaint |
Shortness
of breath |
Pseudo-obstruction |
Shortness
of breath |
Pseudo-obstruction |
Toe
ulceration |
Raynaud’s (duration) |
- |
+ (1
years) |
+ (20
years) |
+
(unknown) |
+ (3
years) |
Esophageal involvment |
+ |
+ |
+ |
+ |
- |
Proximal Skin involvement |
+ |
+ |
+ |
+ |
+ |
Scleroderma facies |
+ |
+ |
+ |
+ |
+ |
Telangiectasias |
- |
- |
+ |
- |
- |
Synovitis |
- |
- |
- |
- |
- |
ANA |
1:640 |
1:640 |
1:640 |
1:10,240 |
Not
collected |
Anti-centromere B |
- |
- |
+ (87) |
- |
+ (155) |
Anti-Scl-70 |
- |
- |
- |
- |
Not
collected |
Comorbidities |
CAD |
Pituiatary adenoma |
CAD |
Renel cell carcinoma |
PAD |
|
DM type
II |
Hypothyroidism |
HTN |
DM type
II |
DM type
II |
|
Osteopenia |
HTN |
Cervical
spinal fusion |
CHF |
HTN |
|
BPPV |
Osteopenia |
|
Asthama |
|
ANA:
antinuclear antibody; CAD: coronary artery diseases; DM: diabetes mellitus;
BPPV: benign paroxysmal positional vertigo; HTN: hypertension; CHF: congestive
heart failure.